Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy
Journal Article
Overview
publication date
- August 1, 1999
has subject area
- Adrenal Gland Diseases - Adrenal Gland Neoplasms
- Adult
- Aged
- Alkaloids - Vincristine
- Benzene Derivatives - 3-Iodobenzylguanidine
- Combined Modality Therapy
- Diagnostic Imaging - Radionuclide Imaging
- Diagnostic Techniques, Radioisotope - Radionuclide Imaging
- Diagnostic Uses of Chemicals - Radiopharmaceuticals
- Drug Therapy - Antineoplastic Combined Chemotherapy Protocols
- Drug Therapy, Combination - Antineoplastic Combined Chemotherapy Protocols
- Endocrine System Diseases - Adrenal Gland Neoplasms
- Female
- Guanidines - 3-Iodobenzylguanidine
- Humans
- Hydrocarbons, Iodinated - 3-Iodobenzylguanidine
- Imidazoles - Dacarbazine
- Indicators and Reagents - Radiopharmaceuticals
- Indoles - Vincristine
- Indolizidines - Vincristine
- Male
- Middle Aged
- Molecular Mechanisms of Pharmacological Action - Radiopharmaceuticals
- Neoplasms by Site - Adrenal Gland Neoplasms
- Neoplasms, Germ Cell and Embryonal - Pheochromocytoma
- Neoplasms, Nerve Tissue - Pheochromocytoma
- Nitrogen Mustard Compounds - Cyclophosphamide
- Organophosphorus Compounds - Cyclophosphamide
- Therapeutics - Antineoplastic Combined Chemotherapy Protocols
- Triazenes - Dacarbazine
has restriction
- closed
Date in CU Experts
- May 20, 2023 5:08 AM
Full Author List
- Sisson JC; Shapiro B; Shulkin BL; Urba S; Zempel S; Spaulding S
author count
- 6
citation count
- 71
published in
Other Profiles
International Standard Serial Number (ISSN)
- 0277-3732
Digital Object Identifier (DOI)
Additional Document Info
start page
- 364
end page
- 370
volume
- 22
issue
- 4